Journal

Stem Cell Therapy Tijuana or Cancún: Key Criteria

Comparing stem cell therapy in Tijuana and Cancún means evaluating criteria, not cities. Here is what to examine before you choose a clinic in Mexico.

Longevia MedicalNovember 13, 2026Leer en español

One decision. Criteria that travel with you.

When patients in the U.S. or Canada begin researching stem cell therapy in Mexico, Tijuana comes up first. The border location makes it the most accessible point of entry for many North American patients, and a large number of clinics have built their visibility around that proximity. Cancún enters the conversation later, usually once a patient has spent time reading and wants to understand what a longer trip might offer in exchange. The honest answer is that geography is almost never the deciding factor. The criteria that determine whether a clinic is appropriate for you are the same in Tijuana, Cancún or any other city in Mexico.

This article walks through those criteria one by one. We are the clinical team at Longevia Medical in Puerto Cancún, and we are not writing this to argue that one city is better than the other. We are writing it because patients who arrive informed make better decisions, and because the questions you should be asking are the same regardless of which city you are considering.

Stem cell therapy in Tijuana, Mexico: what volume tells you and what it does not

Tijuana has more clinics offering stem cell therapy than any other city in Mexico. That volume reflects demand, not uniformity. Within the same city you will find practices with formal COFEPRIS registration, qualified physicians and documented protocols sitting alongside operations with none of those things. Volume, in other words, is not a quality signal. It is simply a fact about the market.

The border location creates a specific dynamic. The short drive from San Diego means patients can often arrange a visit without overnight travel, which lowers the logistical barrier. It also means that some clinics operate with a high turnover model, optimized for volume rather than for clinical depth. Neither of these things is unique to Tijuana; they exist wherever demand is high. What matters is how a specific clinic behaves when you ask the questions below.

Volume is not a quality signal. It is simply a fact about the market. The criteria that protect you are the same in every city.

COFEPRIS registration and physician credentials: the first filter

COFEPRIS is Mexico's federal health regulatory authority. A clinic offering cell-based therapies in Mexico should be able to show you its COFEPRIS registration, and the physician directing care should hold a current cedula profesional, the federal licence that identifies a registered Mexican physician. These are not optional details. They are the starting point for any evaluation.

Beyond the basic licence, look at the academic formation of the physician responsible for the regenerative area. A background in biomedical research, molecular biology or a related graduate discipline matters because cell-based therapies are still an active area of clinical investigation. The physician overseeing your care should be able to explain what the current evidence supports, what remains under study and what does not apply to your situation. If that distinction is not offered clearly, that is a clinical signal.

At Longevia Medical, the physician responsible for regenerative care is Dr. María Guadalupe Navarro Barrientos, Physician, Surgeon and Homeopath (IPN); Molecular Biomedicine (IPN); Medical Research, IPN School of Medicine. Her academic formation is in the field. We mention this not to compare ourselves with other clinics but because it illustrates what an appropriate credential base looks like in this specialty area.

What the evidence supports, what is under study and what does not apply

This distinction is the most important thing a clinic can communicate, and the most commonly omitted. Stem cell science is not a single body of settled knowledge. Some applications are well-characterized in the medical literature. Others are in active clinical investigation. Others are proposed without meaningful support. A clinic that presents all three categories as equivalent is not operating with clinical honesty.

What is accepted: certain cell-based therapies have regulatory approval in specific countries for specific indications, primarily in hematology. Those approvals are narrow and condition-specific. They do not extend automatically to other conditions.

What is under study: a wide range of applications, including orthopedic, autoimmune, neurological and metabolic indications, are in various stages of clinical investigation. Results vary by condition, cell type, preparation method and patient profile. No one can promise outcomes in these areas, and a physician who does is not speaking from evidence.

What does not apply: claims of reversal of advanced degenerative disease, cure of conditions with no established cell-based mechanism, or universal anti-aging effects without individual assessment are not supported by current evidence. If a clinic makes these claims, that is a reason to look elsewhere.

For patients who want to read further into the general science of stem cells and regenerative biology, our article on what stem cells are used for: evidence and limits walks through these categories in more detail.

A clinic that presents accepted applications, investigational applications and unsupported claims as equivalent is not operating with clinical honesty.

Cell handling, laboratory standards and the chain of custody

The biological integrity of the cells used in therapy depends entirely on how they are prepared, stored and administered. This is a technical area where the difference between a compliant and a non-compliant operation is not visible to the patient on arrival. It requires asking directly.

Questions worth asking any clinic in any city include: Where are the cells processed? What quality controls are applied to the preparation? Is the cell handling facility registered with COFEPRIS or an equivalent authority? What is the protocol if a preparation does not meet quality standards? A clinic that cannot answer these questions with specifics either does not have them or does not consider them important. Both are relevant findings.

In general, cell-based therapies involve biological materials that degrade under improper conditions. Temperature control, sterility and timing between preparation and administration are not administrative details. They are the conditions under which the therapy either retains its intended properties or does not. This is equally true in Tijuana and in Cancún.

Individual assessment and written protocol: what continuity looks like

A clinic that offers a standard procedure to every patient, regardless of medical history, current status or objective, is not practicing individualized medicine. Stem cell therapy indications depend on a careful assessment of the patient's specific situation. What applies to one person may not apply to another, and the protocol should reflect that.

Before any intervention, a patient should receive a written plan that identifies the indication, the protocol, the number of sessions, and what follow-up looks like after they return home. That document is not a marketing piece. It is the clinical record of what was decided and why. If a clinic does not produce it, you have no basis for evaluating whether what was done was appropriate for you.

At Longevia Medical, care begins with an assessment, in person or remote. The plan is individual and provided in writing. Follow-up continues after you return home. Whether a given protocol applies to your situation is determined in that assessment, and that is the only honest answer we can give before it happens.

Our article on how to evaluate a stem cell therapy clinic in Mexico expands on what a proper assessment and written protocol should contain.

The written plan is not a marketing piece. It is the clinical record of what was decided and why, and without it you have no basis for evaluating your care.

Follow-up after you return home: the criterion most clinics skip

Travel-based medicine creates a structural gap that most clinics do not address. The intervention happens during your visit. The response to that intervention happens over weeks and months after you leave. If the clinic's relationship with you ends at discharge, you are managing that period without clinical support.

This is not a minor gap. Changes in biomarkers, unexpected responses, and questions about whether to continue, modify or pause a protocol all arise during the post-visit period. A clinic that does not have a follow-up structure is not equipped to interpret what happens after the intervention, which means it cannot evaluate whether what it did was effective or appropriate.

When comparing clinics in Tijuana or Cancún or anywhere else in Mexico, ask specifically: what does follow-up look like after I go home? Who is responsible for it? What triggers a reassessment? The answer to these questions tells you whether the clinic thinks of your care as an event or as a process.

Stem cell therapy in Tijuana versus Cancún: travel logistics and what they mean clinically

Tijuana is a two-hour drive from the greater Los Angeles area and a short commute from San Diego. That accessibility is real and relevant. For a patient who needs multiple sessions, lives on the West Coast, and has a clear protocol that requires return visits, the logistics of Tijuana may be genuinely advantageous.

Cancún involves a flight for most North American patients. That is a higher logistical threshold. What it offers in return is a different environment: a dedicated travel period that some patients find easier to use for the combination of medical care, recovery and monitoring. Neither of these is intrinsically better. They reflect different patient situations and different protocol structures.

The question to ask is not which city is closer, but which travel pattern your protocol actually requires. A single extended visit with remote follow-up is a different logistical shape than multiple short border crossings. Once you understand what your protocol calls for, the travel decision often resolves itself.

What does not resolve itself through logistics is clinical quality. A shorter drive does not substitute for COFEPRIS registration, physician credentials, documented cell handling or written follow-up. Those criteria apply regardless of how far you travel.

Safety, monitoring and what needs emergency care

Any cell-based intervention carries a risk profile that should be explained to you before the procedure, not after. In general, risks include local reactions at the administration site, systemic responses, and, in rare cases, more serious events. A clinic should be able to describe what it monitors for, what its response protocol is if something occurs during a session, and what a patient should watch for after returning home.

If after any injection or cell-based procedure you experience sudden changes in vision, skin that turns white or dusky at the injection site, difficulty breathing, chest pain or new neurological symptoms, these require emergency care immediately. Do not send a message to the clinic. Go to the nearest emergency department or call emergency services.

This applies in every city and with every provider. Proximity to a clinic is not the same as proximity to emergency infrastructure.

Frequently Asked Questions

Is stem cell therapy in Tijuana, Mexico regulated by the government?

Mexico's federal regulatory authority, COFEPRIS, oversees clinics offering cell-based therapies. A clinic in Tijuana or any other Mexican city should be able to show its COFEPRIS registration and the physician's federal licence. These are the starting point for any evaluation, not an optional detail.

How does stem cell therapy in Tijuana compare with Cancún in terms of clinical quality?

Clinical quality depends on the specific clinic, not the city. The criteria that matter, including COFEPRIS registration, physician credentials, cell handling standards, individual assessment and written follow-up, are the same in Tijuana and Cancún. Evaluating those criteria directly is more reliable than choosing by location.

What conditions is stem cell therapy currently accepted for?

Regulatory approval for cell-based therapies exists in specific countries for narrow indications, primarily in hematology. A wide range of other applications are in active clinical investigation. No one can promise outcomes in investigational areas. The indication that applies to you is determined through an individual clinical assessment.

What should a stem cell therapy protocol in Mexico include?

A sound protocol begins with an individual assessment, produces a written plan that identifies the indication, the number of sessions and the follow-up structure, and includes monitored care after the patient returns home. Protocols that apply the same procedure to every patient without individual assessment do not meet this standard.

Can I have a remote assessment before traveling to Mexico for stem cell therapy?

Yes. At Longevia Medical in Puerto Cancún, care begins with an assessment that can be conducted in person or remotely. The individual plan is provided in writing, and follow-up continues after you return home. Whether a specific protocol applies to your situation is determined through that assessment.

For patients who want to read further into how the general science of stem cells and regenerative therapy is described by independent medical sources, Mayo Clinic and MedlinePlus both publish general health information on these topics.

Begin privately

Tell us what you want to protect.

This first conversation is for orientation, not diagnosis. A coordinator will identify the right clinical pathway and explain the secure next step.

Request a private consultation↗

Book a private consultation

Tell us what you want to protect.

Choose a preferred date and time. A coordinator confirms your appointment by WhatsApp or email and explains the secure next step. This first conversation is for orientation, not diagnosis.

Do not include medical records or sensitive health information here.
Thank you. We received your request. A coordinator will confirm your appointment by WhatsApp or email.